Serum resistin levels in nonalcoholic fatty liver disease and their relationship to severity of liver disease

References

• Wolf G. Insulin resistance and obesity: Resistin, a hormone secreted by adipose tissue. Nutr Rev 2004; 62(10)389–394.
   PubMed Web of Science ®Google Scholar
• Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation defines a new gene family. EMBO J 2000; 19(15)4046–4055.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276(14) 11252–11256.
   PubMed Web of Science ®Google Scholar
• Sato N, Kobayashi K, Inoguchi T, et al. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 2005; 146(1): 273–279.
   PubMed Web of Science ®Google Scholar
• Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003; 111:225–230.
   PubMed Web of Science ®Google Scholar
• Muse ED, Obici S, Bhanot S, et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114:232–239.
   PubMed Web of Science ®Google Scholar
• Ukkola O. Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 2002; 147: 571–574.
   PubMed Web of Science ®Google Scholar
• Pagano C, Marin O, Calcagno A, et al. Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005; 90: 4335–4340.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Kawasaki F, Yamada K, et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med 2004; 21: 881–888.
   PubMed Web of Science ®Google Scholar
• Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metabol 2006; 91: 64–68.
   PubMed Web of Science ®Google Scholar
• Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005; 7: 406–413.
   PubMed Web of Science ®Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221–1231.
   PubMed Web of Science ®Google Scholar
• American Gastroenterology Association Medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1702–1704.
   PubMedGoogle Scholar
• Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917–923.
   PubMed Web of Science ®Google Scholar
• Comlekci, A., H. Akpinar, S. Yesil, I. Okan, E. Ellidokuz, A. Okan, G. Ersoz, E. Tankurt, Y. Batur, Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis. Scand J Gastroenterol, 2003, 38(7): 779–786.16. Pagano C, Soardo G, Pilon C, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006; 91(3): 1081–1086.
   PubMed Web of Science ®Google Scholar
• Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26–31.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41 (6): 1313–1321.
   PubMed Web of Science ®Google Scholar
• Fujinami A, Obayashi H, Ohta K, et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004; 339: 57–63.
   PubMed Web of Science ®Google Scholar
• Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese, humans. J Clin Endocrinol Metab 2003; 88(11): 5452–5455.
   PubMed Web of Science ®Google Scholar
• Volarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004; 53: 1279–1284.
   PubMed Web of Science ®Google Scholar
• Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 2004; 81: 361–366.
   PubMed Web of Science ®Google Scholar
• Silha JV, Murphy LJ. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2004; 89: 1977–1978.
   PubMed Web of Science ®Google Scholar
• Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 2004; 28(6): 783–789.
   PubMed Web of Science ®Google Scholar
• Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin: concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 63–69.
   PubMedGoogle Scholar
• Yagmur, E., C. Trautwein, A.M. Gressner, F. Tacke, Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol, 2006; 101 (6): 1244–52.
   PubMed Web of Science ®Google Scholar
• Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611–1618.
   PubMed Web of Science ®Google Scholar
• Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195–1198.
   PubMed Web of Science ®Google Scholar
• Rangwala SM, Rich AS, Rhoades B, et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004; 53: 1937–1941.
   PubMed Web of Science ®Google Scholar
• Ankarberg-Lindgren C, Dahlgren J, Carlsson B, et al. Hormone adiponectin alleviates nonalcoholic fatty liver diseases. Eur J Endocrinol 2001; 145: 43–51.
   PubMed Web of Science ®Google Scholar
• Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB. Elevated adipokines levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 2001; 86: 1188–1193.
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Nicolson M, Levine LS, et al. Effect of puberty on the relationship between circulating adipokines and body composition. J Clin Endocrinol Metab 2001; 85: 1509–1518.
   Google Scholar
• Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998; 115: 997–1001.
   PubMed Web of Science ®Google Scholar
• Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413–419.
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27–41.
   PubMed Web of Science ®Google Scholar
• Diehl AM. Nonalcoholic steatosis and steatohepatitis. IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol 2002; 282: G1–G5.
   PubMed Web of Science ®Google Scholar
• Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611–1618.
   PubMed Web of Science ®Google Scholar
• Cho YM, Youn BS, Chung SS, et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004; 47: 1337–1338.
   Web of Science ®Google Scholar
• Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab 2006; 91: 64–68.
   PubMed Web of Science ®Google Scholar